Rapidly increasing prescribing of proton pump inhibitors in primary care despite interventions: A nationwide observational study

European Journal of General Practice

Volumn 20, Issue 4, 2014, Pages 290-293

  Haastrup, Peter ^a   Paulsen, Maja Skov ^a   Zwisler, Jon Eik ^a   Begtrup, Luise Molenberg ^a   Hansen, Jane Moller ^b   Rasmussen, Sanne ^a   Jarbol, Dorte Ejg ^a  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^b ODENSE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Dyspepsia; Pharmacoepidemiology; Primary health care; Proton pump inhibitors; Reimbursement modifications

Indexed keywords

LANSOPRAZOLE; OMEPRAZOLE; PANTOPRAZOLE; PROTON PUMP INHIBITOR;

ADULT; AGED; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DANISH CITIZEN; DENMARK; DRUG MARKETING; FEMALE; GENERAL PRACTICE; HUMAN; MALE; OBSERVATIONAL STUDY; PHARMACOEPIDEMIOLOGY; PRACTICE GUIDELINE; PRESCRIPTION; PRIMARY HEALTH CARE; PRIMARY MEDICAL CARE; REIMBURSEMENT; CLINICAL PRACTICE; PEPTIC ULCER; REGISTER; RETROSPECTIVE STUDY; STANDARDS; STATISTICS AND NUMERICAL DATA;

AGED; DENMARK; FEMALE; GUIDELINE ADHERENCE; HUMANS; MALE; PEPTIC ULCER; PHYSICIAN'S PRACTICE PATTERNS; PRIMARY HEALTH CARE; PROTON PUMP INHIBITORS; REGISTRIES; RETROSPECTIVE STUDIES;

EID: 84910684111     PISSN: 13814788     EISSN: 17511402     Source Type: Journal    
DOI: 10.3109/13814788.2014.905535     Document Type: Article

References (12)

1. Report on the annual sale of medicines. Copenhagen, Denmark: Statens Serum Institut. Available at http://www.medstat.dk (accessed 1 September 2012).
2. Mabbott V, Robinson M, Segrave A, Brennan Q. Department of Health and Ageing-Australian statistics on medicines 2010. Canberra, Australia: Department of Health. Available at http://www. pbs.gov.au/statistics/asm/2010/australian-statistics-on-medicine-2010.pdf (accessed 1 November 2012).
3. Lassen A, Hallas J, Schaff alitzky de Muckadell OB. Use of antise-cretory medication: A population-based cohort study. Aliment Pharmacol Ther. 2004;20:577-83.
4. Moayyedi P, Leontiadis GI. The risks of PPI therapy. Nat Rev Gastroenterol Hepatol. 2012;9:132-9.
5. Reimer C, Sondergaard B, Hilsted L, Bytzer P. Proton-pump inhibitor therapy induces acid-related symptoms in healthy volunteers after withdrawal of therapy. Gastroenterology 2009; 137: 80-7.
6. Talley NJ, Vakil NB, Moayyedi P. American Gastroenterological Association technical review on the evaluation of dyspepsia. Gastroenterology 2005;129:1756-80.
7. Pedersen KM, Andersen JS, Søndergaard J. General practice and primary health care in Denmark. J Am Board Fam Med. 2012; 25:34-8.
8. http://www.ema.europe.eu/ema (accessed 1 October 2012).
9. Grimshaw JM, Thomas RE, MacLennan G, Fraser C, Ramsay CR, Vale L, et al. Effectiveness and efficiency of guidelines dissemination and implementation strategies. Health Technol Assess. 2004;8:1-72.
10. Jonasson C, Tvete IF, Hatlebakk JG. Patterns of proton pump inhibitor utilization in gastroesophageal reflux disease and the Effect of restrictions on reimbursement: A nationwide prescription database study. Scand J Gastroenterol. 2013;48:1010-7.
11. Krol N, Wensing M, Haaijer-Ruskamp F, Muris JW, Numans ME, Schattenberg G, et al. Patient-directed strategy to reduce prescribing for patients with dyspepsia in general practice: A randomized trial. Aliment Pharmacol Ther. 2004;19:917-22.
12. Spijker-Huiges A, Winters JC, Meyboom-de Jong B. Patients'view on dyspepsia and acid suppressant drug therapy in general practice. Eur J Gen Pract. 2006;12:10-4.